SIROLIMUS延緩衰老雷帕黴素(西羅莫司)免疫抑制劑

SIROLIMUS延緩衰老雷帕黴素(西羅莫司)免疫抑制劑

SIROLIMUS延緩衰老雷帕黴素(西羅莫司)免疫抑制劑，日文也稱為 ラパリムス錠 1mg是一種口服處方藥，含有 西羅莫司 1mg西羅莫司，在研究文獻中也被廣泛稱為雷帕黴素，是一種 mTOR抑制劑 在專業醫療監督下使用。

RAPALIMUS 1mg 錠劑由日本 Nobelpharma Co., Ltd.（諾貝爾製藥株式會社）生產並銷售。每片含有 1mg 西羅莫司。本產品為口服片劑，僅限處方使用。

產品資訊：

• 產品名稱： SIROLIMUS延緩衰老雷帕黴素(西羅莫司)免疫抑制劑
• 日文名稱： ラパリムス錠 1mg
• 通用名稱： Sirolimus Tablets 1mg
• Research Name: Rapamycin Tablets 1mg
• 中文名稱： 雷帕立慕斯錠 1mg / 西羅莫司片 1mg
• 活性成分： 西羅莫司
• Japanese Ingredient: シロリムス
• 強度: 1mg per tablet
• Package Size: 30片
• 劑型： 藥片
• 路線 口服
• 藥物類別： mTOR inhibitor / immunosuppressive agent
• 製造商： Nobelpharma Co., Ltd.
• 日本製造商： ノーベルファーマ株式会社
• 使用等級：處方藥 / 需在專業醫療監督下使用

什麼是雷帕利莫司（RAPALIMUS）1毫克錠？

RAPALIMUS 1mg 錠劑含有西羅莫司（一種 mTOR 抑制劑）。 mTOR 路徑參與細胞生長、增殖、代謝及免疫調節過程。透過抑制 mTOR 訊號傳導，西羅莫司能夠在特定醫學狀況下調節免疫及細胞活性。

在日本，拉帕利姆斯（Rapalimus）片（1mg）用於淋巴管平滑肌瘤病以及某些難治性血管或淋巴系統疾病等專業醫療領域。治療應始終在具備相應資格的醫療專業人員指導下進行，並根據需要對臨床療效、安全性和血中濃度進行適當監測。

主要優點

• Contains sirolimus 1mg per tablet
• mTOR inhibitor with immunomodulating activity
• Used under specialist medical supervision
• Associated with treatment of lymphangioleiomyomatosis
• Associated with treatment of certain refractory lymphatic or vascular diseases
• 口服錠劑
• Manufactured by Nobelpharma Co., Ltd. in Japan
• Prescription-use medicine requiring clinical monitoring

適應症和用途

This product is generally associated with professional medical treatment for:

• Lymphangioleiomyomatosis, also known as LAM
• Refractory lymphatic diseases
• Lymphangioma / lymphatic vascular malformation
• Lymphangiomatosis
• Gorham disease
• Lymphangiectasia
• Refractory vascular tumors and vascular malformations, where clinically appropriate
• Specialist immunomodulatory treatment under medical supervision

Use must follow the official prescribing information, physician assessment, patient condition, and applicable local regulations. This product should not be used for self-medication.

Research and Anti-Aging Interest

Sirolimus / rapamycin has attracted scientific and public attention because of its role in the mTOR pathway, a pathway involved in metabolism, cellular growth, and aging-related research. It has also been discussed in longevity-related media and documentaries, including public interest around biohacking and longevity figures.

However, anti-aging or longevity use is not the same as an approved medical indication. This product should not be presented as a guaranteed anti-aging medicine, longevity supplement, beauty product, or wellness supplement. Any off-label consideration must be discussed with a qualified healthcare professional.

劑量和用法

• This product is taken orally.
• Use only as prescribed by a qualified healthcare professional.
• Dosage depends on the patient’s diagnosis, body surface area, clinical condition, treatment response, and blood trough concentration where applicable.
• For lymphangioleiomyomatosis, a commonly referenced adult dosage is sirolimus 2mg once daily, adjusted according to patient condition, with a maximum of 4mg once daily.
• For refractory lymphatic disease, the starting dose may vary according to body surface area, with subsequent adjustment based on blood trough concentration and clinical response.
• Take consistently at the same time each day unless otherwise directed by a healthcare provider.
• Do not start, stop, increase, reduce, or change the dosing schedule without medical advice.

Important Use Clarification

RAPALIMUS TABLETS 1MG is a prescription mTOR inhibitor medicine. It is not a dietary supplement, not a general anti-aging supplement, not a cosmetic medicine, not a skin booster, not a dermal filler, not a water-light injection, and not a weight management product.

預防措施

• Prescription medicine; use only under medical supervision.
• Not suitable for self-medication or unsupervised longevity use.
• Do not use if allergic to sirolimus, rapamycin, or any component of the product.
• Use caution in patients with liver dysfunction, infection, lung disease, kidney problems, abnormal lipid levels, diabetes, poor wound healing, or immunocompromised conditions.
• May increase susceptibility to infections due to immunosuppressive effects.
• Vaccination plans should be discussed with a healthcare provider.
• Pregnant or breastfeeding individuals should consult a healthcare provider before use.
• Regular blood tests and clinical monitoring may be required.
• Blood trough concentration monitoring may be required depending on indication and physician instructions.
• Inform your healthcare provider about all medicines, supplements, and herbal products before use.

可能的副作用

可能出現的副作用包括：

• Mouth ulcers or stomatitis
• Rash or acne-like skin symptoms
• 腹瀉
• 噁心或胃腸道不適
• 頭痛
• Swelling or edema
• Increased blood lipid levels
• Delayed wound healing
• Increased risk of infection
• Abnormal blood test results

Serious but less common risks may include severe infection, interstitial lung disease or lung inflammation, kidney-related problems, liver function abnormalities, severe allergic reaction, blood disorders, or serious metabolic abnormalities. Seek medical attention immediately if symptoms such as fever, persistent cough, shortness of breath, chest pain, severe rash, unusual bleeding, severe mouth ulcers, swelling, or signs of infection occur.

藥物交互作用

Sirolimus may interact with various medicines and substances. Patients should inform their healthcare provider about all prescription medicines, over-the-counter medicines, supplements, herbal products, and dietary habits. Some medicines may increase or decrease sirolimus blood levels, affecting safety and effectiveness.

Do not combine with other medicines or supplements without professional advice.

貯存

• Store according to the official product packaging or prescribing information.
• Keep away from direct sunlight, heat, and moisture.
• Store in the original package until use.
• 請將本品放在兒童不能接觸的地方。
• Do not use after the expiry date printed on the packaging.

Package Contents

• SIROLIMUS延緩衰老雷帕黴素(西羅莫司)免疫抑制劑
• 30 tablets per box
• Each tablet contains sirolimus 1mg

重要免責聲明

This product information is provided for general product reference and SEO description purposes only. It does not replace professional medical advice, diagnosis, treatment, official prescribing information, or product labeling. RAPALIMUS TABLETS 1MG should be used only under the supervision of a qualified healthcare professional according to applicable medical standards and local regulations.